Dr. Bansal joined the faculty at Mount Sinai in 2001 after completing her gastroenterology fellowship at the University of Pennsylvania. In 2002, she became Director of the Transplant Hepatology Fellowship, overseeing one of the largest transplant fellowship programs of its kind in the United States. Both clinically and scientifically, she has mentored well over 80 trainees, shaping the careers of the next generation of academic hepatologists.

From 2013-2021, in addition to maintaining an NIH funded research program focused on molecular mechanism of liver fibrosis with seminal contributions to our understanding of liver fibrosis in people living with HIV, Dr. Bansal held many different leadership roles at Mount Sinai, including Director of Translational Research, Medical Director of Hospital-Based Clinics, Chief Medical Officer of Mount Sinai Care, LLC, Deputy Chief Medical Officer for Mount Sinai Health Partners, and Vice President of Population Health for Quality and Efficiency. In these roles, she helped generate increased quality dollars in value-based contracts, created Mount Sinai’s first ambulatory pharmacy program, addressed broad population health needs, and gained knowledge about payer relations in an ever-changing health care landscape.

At the international/national levels, she has chaired numerous committees and held the position of Secretary for the American Association for the Study of Liver and currently serves as the Director of the newly formed NAFLD/NASH (MASLD/MASH) Center of Excellence at Mount Sinai.

Most recently, in January 2024, Dr. Bansal was named System Chief, Division of Liver Diseases for the Mount Sinai Health System.